These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
3950 related items for PubMed ID: 18761360
1. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM. Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360 [Abstract] [Full Text] [Related]
2. Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents. Benmansour S, Deltheil T, Piotrowski J, Nicolas L, Reperant C, Gardier AM, Frazer A, David DJ. Eur J Pharmacol; 2008 Jun 10; 587(1-3):90-8. PubMed ID: 18474368 [Abstract] [Full Text] [Related]
3. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression. Szapacs ME, Mathews TA, Tessarollo L, Ernest Lyons W, Mamounas LA, Andrews AM. J Neurosci Methods; 2004 Dec 30; 140(1-2):81-92. PubMed ID: 15589338 [Abstract] [Full Text] [Related]
4. Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: studies in adult mice hippocampus. Deltheil T, Guiard BP, Guilloux JP, Nicolas L, Deloménie C, Repérant C, Le Maitre E, Leroux-Nicollet I, Benmansour S, Coudoré F, David DJ, Gardier AM. Pharmacol Biochem Behav; 2008 Aug 30; 90(2):174-83. PubMed ID: 17980409 [Abstract] [Full Text] [Related]
5. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. Ren-Patterson RF, Cochran LW, Holmes A, Sherrill S, Huang SJ, Tolliver T, Lesch KP, Lu B, Murphy DL. J Neurosci Res; 2005 Mar 15; 79(6):756-71. PubMed ID: 15672416 [Abstract] [Full Text] [Related]
6. Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice. Deltheil T, Tanaka K, Reperant C, Hen R, David DJ, Gardier AM. Int J Neuropsychopharmacol; 2009 Aug 15; 12(7):905-15. PubMed ID: 19236729 [Abstract] [Full Text] [Related]
7. Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor. Gardier AM. Behav Pharmacol; 2009 Feb 15; 20(1):18-32. PubMed ID: 19179848 [Abstract] [Full Text] [Related]
8. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM. J Neurosci Methods; 2004 Dec 30; 140(1-2):169-81. PubMed ID: 15589347 [Abstract] [Full Text] [Related]
9. Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. Guiard BP, David DJ, Deltheil T, Chenu F, Le Maître E, Renoir T, Leroux-Nicollet I, Sokoloff P, Lanfumey L, Hamon M, Andrews AM, Hen R, Gardier AM. Int J Neuropsychopharmacol; 2008 Feb 30; 11(1):79-92. PubMed ID: 17559709 [Abstract] [Full Text] [Related]
10. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice. Lindholm JS, Autio H, Vesa L, Antila H, Lindemann L, Hoener MC, Skolnick P, Rantamäki T, Castrén E. Neuropharmacology; 2012 Jan 30; 62(1):391-7. PubMed ID: 21867718 [Abstract] [Full Text] [Related]
11. Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. Keck ME, Sartori SB, Welt T, Müller MB, Ohl F, Holsboer F, Landgraf R, Singewald N. J Neurochem; 2005 Mar 30; 92(5):1170-9. PubMed ID: 15715667 [Abstract] [Full Text] [Related]
12. Brain-derived neurotrophic factor expression is increased in the hippocampus of 5-HT(2C) receptor knockout mice. Hill RA, Murray SS, Halley PG, Binder MD, Martin SJ, van den Buuse M. Hippocampus; 2011 Apr 30; 21(4):434-45. PubMed ID: 20087884 [Abstract] [Full Text] [Related]
13. Isoflurane decreases extracellular serotonin in the mouse hippocampus. Whittington RA, Virág L. Anesth Analg; 2006 Jul 30; 103(1):92-8, table of contents. PubMed ID: 16790633 [Abstract] [Full Text] [Related]
14. Dietary restriction changes behaviours in brain-derived neurotrophic factor heterozygous mice: role of serotonergic system. Koizumi H, Hashimoto K, Iyo M. Eur J Neurosci; 2006 Oct 30; 24(8):2335-44. PubMed ID: 17074054 [Abstract] [Full Text] [Related]
15. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Xu Y, Ku B, Cui L, Li X, Barish PA, Foster TC, Ogle WO. Brain Res; 2007 Aug 08; 1162():9-18. PubMed ID: 17617388 [Abstract] [Full Text] [Related]
16. Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice. Luellen BA, Bianco LE, Schneider LM, Andrews AM. Genes Brain Behav; 2007 Jul 08; 6(5):482-90. PubMed ID: 17156118 [Abstract] [Full Text] [Related]
17. Effects of serotonin depletion on the hippocampal GR/MR and BDNF expression during the stress adaptation. Zhou J, Li L, Tang S, Cao X, Li Z, Li W, Li C, Zhang X. Behav Brain Res; 2008 Dec 16; 195(1):129-38. PubMed ID: 18601957 [Abstract] [Full Text] [Related]
18. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS. Biol Psychiatry; 2007 Mar 01; 61(5):661-70. PubMed ID: 16945347 [Abstract] [Full Text] [Related]
19. Potential antidepressant properties of cysteamine on hippocampal BDNF levels and behavioral despair in mice. Shieh CH, Hong CJ, Huang YH, Tsai SJ. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1590-4. PubMed ID: 18582526 [Abstract] [Full Text] [Related]
20. Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor. Vinet J, Carra S, Blom JM, Brunello N, Barden N, Tascedda F. Neuropharmacology; 2004 Dec 01; 47(7):1062-9. PubMed ID: 15555640 [Abstract] [Full Text] [Related] Page: [Next] [New Search]